Description
Oxcarbazepine Tablet
Oxcarbazepine Tablets (150 mg / 300 mg / 600 mg)
Healthy Life Pharma Private Limited, alongside our specialized global marketing and export division Healthy Inc, is a premier manufacturer, supplier, and exporter of advanced neurology, psychiatry, and central nervous system (CNS) therapeutics. We manufacture ultra-high-purity, kinetically stable Oxcarbazepine Tablets within our WHO–GMP certified, high-containment solid dosage manufacturing facilities. This modern “Voltage-Gated Sodium Channel Stabilizer” serves as a major strategic product for neurology centers, psychiatric hospital networks, international B2B wholesale marketplaces, and state tender procurement pipelines across Europe, the CIS region, Africa, LATAM, and Southeast Asia.
Product Overview
This formulation operates as a “Neuronal Hyper-Excitability Suppressor.” It ensures patient safety by restricting the repetitive firing of action potentials across hyperactive brain pathways, successfully controlling epileptic seizures and stabilizing mood profiles.
Mechanism 1 (Active Monohydroxy Transformation): Oxcarbazepine is a structural prodrug. Upon ingestion, it is physically and rapidly converted by cytosolic enzymes into its chemically active pharmacophore, the Monohydroxy Derivative (MHD).
Mechanism 2 (Voltage-Gated Sodium Channel Blockade): The active MHD molecule physically binds to and chemically stabilizes the inactivated state of voltage-gated sodium channels. This physically blocks influx currents, preventing the spread of high-frequency electrical discharges from a seizure focus.
Mechanism 3 (Potassium Channel Modulation): It chemically increases potassium conductance and modulates high-voltage activated calcium channels, physically dampening chaotic synaptic transmission across overstimulated central nervous system networks.
Product Composition & Available Strengths
We manufacture Oxcarbazepine in the full, internationally standardized range of strengths to allow for the precise, progressive dose titration mandatory in anti-epileptic therapy.
| Active Ingredient | Available Strengths | Primary Clinical Target |
| Oxcarbazepine IP / BP / USP | 150 mg | Pediatric & Initial Titration: For low-dose introductory phases to assess patient tolerance. |
| Oxcarbazepine IP / BP / USP | 300 mg | Standard Maintenance: The foundational daily maintenance dose for adolescent and adult stabilization. |
| Oxcarbazepine IP / BP / USP | 600 mg | High-Potency Control: For refractory focal seizures or high-threshold therapeutic stabilization. |
Technical & Logistics Specifications
HS Code: 3004.90.99 (Medicaments acting on the central nervous system / Anticonvulsants)
CAS Number: 28721-07-5 (Oxcarbazepine)
Dosage Form: Oral Solid Tablet (Film-Coated for taste-masking and moisture protection)
Packaging: 10 Tablets per Blister packed in high-barrier Alu-Alu (Cold-Form Foil) or heavy-duty PVC/PVDC matrix strips. Our specialized packaging safeguards the crystalline stability of the active drug, ensuring a full 36-month shelf life in Zone IVb tropical export climates.
Manufacturing Authority & Compliance
Advanced API Micronization: Oxcarbazepine is physically poorly soluble in water, which can hamper systemic absorption. Our processing lines utilize Fluid Energy Jet Micronization, chemically reducing particle sizes to a uniform micro-range, physically maximizing dissolution and bio-availability consistency.
Isolated Neuro-Dosage Production Suites: Because neuro-active molecules demand rigorous cross-contamination controls, our manufacturing facilities execute compression inside Dedicated HVAC-Isolated Negative-Pressure Suites, completely satisfying strict global B2B regulatory audits.
Comparative Dissolution Validation: Every production batch physically undergoes Automated Dissolution Profiling, chemically validating that our generic tablets precisely replicate the kinetic performance profiles of global innovator benchmarks (such as Trileptal).
Primary Indications
Neurology: Monotherapy or adjunctive therapy for the treatment of Partial/Focal Seizures (with or without secondary generalization) in adults and children.
Psychiatry & Pain Management: Off-label stabilization of refractory Bipolar Mood Disorders and symptomatic management of severe Trigeminal Neuralgia.
Usage Instructions
Administration: Swallow the tablet physically whole with a full glass of water. It can be taken consistently either with or without food.
The Titration Rule: Dosing must be chemically managed and escalated slowly under a specialist’s supervision. Never abruptly stop or physically alter the daily dose, as sudden discontinuation can chemically trigger Status Epilepticus (severe, continuous seizures).
Serum Sodium Monitoring: Oxcarbazepine can chemically cause a drop in blood sodium levels (Hyponatremia). Periodic blood chemistry monitoring is physically recommended during the initial months of high-dose management.
Safety Warning: POTENT ANTICONVULSANT AGENT. For Neurology/Psychiatry Specialist Supervision Only. Hyponatremia Risk: May chemically lower serum sodium below normal thresholds; monitor physically if symptoms like confusion, lethargy, or worsening headache occur. Drowsiness Warning: Physically induces central sedation; advise patients against driving or operating automated machinery during initial therapy. Contraindication: Do not use in patients presenting with a history of bone marrow suppression or known hypersensitivity to Oxcarbazepine, Carbamazepine, or any binding excipient.
Global Export & Contract Manufacturing (CDMO Services)
Healthy Life Pharma Private Limited provides complete, internationally validated Third-Party Contract Manufacturing (CDMO) and private-label production for generic Oxcarbazepine Tablets. Whether you are expanding a neuro-psychiatric portfolio across the CIS, bidding for a National Health Authority Tender in Africa, or listing premium inventory on an international digital B2B Pharmaceutical Marketplace in Southeast Asia or LATAM, we deliver all required international documentation (WHO-GMP, COA, COPP, Stability Matrix Records, and complete CTD Dossier sets) for rapid entry clearance.
Commercial & Bulk Procurement Inquiries:
Corporate Head Office: Mumbai, Maharashtra, India
Primary Manufacturing Base: Boisar, Maharashtra, India
WhatsApp / Direct Call: +91 7710003340
Corporate Email: info@healthyinc.co.in
